Aelis Farma SA (AELIS PA) stock market data APIs
€0.9557
0(0%)
as of September 15, 2026
Try our APIs with
free plan!
Aelis Farma SA Financial Data Overview
Price chart is built with
Anychart
Aelis Farma SA, a clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France. The company owns a pipeline of pharmacological inhibitors, including AEF0117, a drug candidate, which is in Phase 2b clinical trials for the treatment of the harmful effects of excessive cannabis use; AEF0217, a drug candidate, which is in phase 1/2 clinical trials to treat cognitive deficits observed in down syndrome; and CB1-SSi, a new molecular entities to treat other CB1-dependent diseases, including several orphan diseases. Aelis Farma SA was incorporated in 2013 and is headquartered in Bordeaux, France.
Prev. Close
0.9557
Open
0.9588
High
0.9634
Low
0.9365
52 wk Range
0.94-2.3
Market Cap
13 090 K
Shares Outstanding
13 635 K
Revenue
2 084 K
Beta
0.622
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Aelis Farma SA data using free add-ons & libraries
Get Aelis Farma SA Fundamental Data
Aelis Farma SA Fundamental data includes:
- Net Revenue: 2 084 K
- EBITDA: -6 109 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-09-15
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aelis Farma SA News
New
European Penny Stocks To Watch In January 2026
As European markets start the year with optimism, the pan-European STOXX Europe 600 Index has risen by 2.27%, buoyed by positive economic signals and a favorable interest rate environment. In this con...
European Penny Stocks To Consider In November 2025
The European market has shown resilience, with the pan-European STOXX Europe 600 Index rising by 1.77% due to relief from the reopening of the U.S. federal government, although enthusiasm for artifici...
3 European Penny Stocks With Market Caps Under €200M
The European market recently faced mixed results, with the pan-European STOXX Europe 600 Index ending slightly lower amid global growth concerns and a stronger euro. For investors looking beyond estab...
Down Syndrome Market Research and Global Forecast Report 2025-2035 | Rising Prevalence, Precision Medicine Advances, R&D Investments, and Advocacy-Driven Awareness Bolster Advances
Company Logo Down syndrome, caused by an extra chromosome 21, impacts physical and intellectual development. Advances in non-invasive prenatal testing (NIPT) and genetic screening offer earlier diagn...
Get Aelis Farma SA fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
